Jay Venkatesan insider trades: Serina Therapeutics (SER) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jay reports to the SEC
and 3 more companies
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | SER | ↑ Buy | 589 | $1.78 | $1K | Direct | Jun 22, 2026 (31d) |
| May 25, 2022 | ANGN | ↑ Buy | 11,313 | $1.25 | $14K | Direct | May 27, 2022 (2d) |
| May 24, 2022 | ANGN | ↑ Buy | 82,200 | $1.23 | $101K | Direct | May 25, 2022 (1d) |
| Dec 28, 2021 | ANGN | ↑ Buy | 277,244 | $2.63 | $730K | Direct | Dec 29, 2021 (1d) |
| Dec 20, 2021 | ANGN | ↑ Buy | 3,527 | $2.54 | $9K | Direct | Dec 22, 2021 (2d) |
| Dec 17, 2021 | ANGN | ↑ Buy | 41,625 | $2.55 | $106K | Direct | Dec 20, 2021 (3d) |
| Dec 15, 2021 | ANGN | ↑ Buy | 77,604 | $2.41 | $187K | Direct | Dec 17, 2021 (2d) |
| Sep 17, 2021 | ALPN | ↓ Sell | 400,000 | $9.40 | $3.8M | By Alpine ImmunoSciences, L.P. | Sep 21, 2021 (4d) |
| Feb 9, 2021 | ANGN | ↓ Sell | 159,177 | $16.00 | $2.5M | Direct | Feb 11, 2021 (2d) |
| Aug 2, 2019 | XCUR | ↑ Buy | 250,000 | $2.00 | $500K | Direct | Aug 6, 2019 (4d) |
| Jan 18, 2019 | ALPN | ↑ Buy | 190,875 | $5.37 | $1.0M | Alpine ImmunoSciences, L.P. | Jan 22, 2019 (4d) |
| Sep 26, 2017 | XCUR | ↑ Buy | 66,666 | $3.00 | $200K | By Ayer Special Situations Fund I, LP | Sep 28, 2017 (2d) |
| Jun 29, 2012 | ACCP | ↓ Sell | 204,157 | $0.57 | $116K | Indirect | Jun 29, 2012 (0d) |
| May 16, 2012 | ACCP | ↓ Sell | 141,300 | $0.67 | $95K | Indirect | May 16, 2012 (0d) |
| Oct 15, 2007 | TARG | ↑ Buy | 575,000 | $10.00 | $5.8M | Indirect | Oct 17, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SER insiders
Open-market trades in the last 12 months
About Jay Venkatesan's insider trades
Jay Venkatesan is a director at Serina Therapeutics (SER). Since Oct 15, 2007, Jay has reported 11 open-market purchases worth $8.6M and 4 sales worth $6.5M on SEC Form 4. In the last 12 months: 1 buy ($1K).
Their filings also include grants and awards (31 filings), option exercises (9 filings), other transactions (6 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SER insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.